Phoenix Holdings Ltd. Kamada LTD Transaction History

Phoenix Holdings Ltd.

$6.92 Billion
Q1 2024

A detailed history of Phoenix Holdings Ltd. transactions in Kamada LTD stock. As of the latest transaction made, Phoenix Holdings Ltd. holds 1,917,477 shares of KMDA stock, worth $9.51 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

1,917,477

Previous 1,917,477 -0.0%

Holding current value

$9.51 Million

Previous $11.7 Million 8.33%

% of portfolio

0.16%

Previous 0.22%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$4.14 - $6.22 $778,510 - $1.17 Million	-188,046 Reduced 8.93%	1,917,477 $11.7 Million
Q4 2022 Feb 13, 2023	BUY	$3.79 - $4.7 $172,869 - $214,376	45,612 Added 2.21%	2,105,523 $8.44 Million
Q3 2022 Nov 10, 2022	BUY	$4.45 - $5.43 $1.01 Million - $1.24 Million	227,819 Added 12.43%	2,059,911 $9.11 Million
Q2 2022 Aug 15, 2022	BUY	$4.22 - $5.85 $22,446 - $31,116	5,319 Added 0.29%	1,832,092 $8.26 Million
Q1 2022 May 10, 2022	BUY	$5.43 - $6.81 $2.95 Million - $3.7 Million	542,636 Added 42.26%	1,826,773 $10.1 Million

Q4 2021 Feb 07, 2022	BUY	$5.21 - $6.82 $1.89 Million - $2.47 Million	362,474 Added 39.33%	1,284,137 $8.45 Million
Q3 2020 Nov 10, 2020	SELL	$8.02 - $11.73 $493,021 - $721,090	-61,474 Reduced 6.25%	921,663 $7.26 Million
Q2 2020 Aug 10, 2020	SELL	$5.37 - $9.45 $268,258 - $472,074	-49,955 Reduced 4.84%	983,137 $7.24 Million
Q1 2020 May 20, 2020	BUY	$4.56 - $7.13 $130,069 - $203,376	28,524 Added 2.84%	1,033,092 $5.88 Million
Q3 2019 Nov 18, 2019	BUY	$5.11 - $5.99 $5.13 Million - $6.02 Million	1,004,568 New	1,004,568 $4.92 Million

Others Institutions Holding KMDA

# of Institutions

Shares Held

5.67M

Call Options Held

300

Put Options Held

151K

View Full List

About KAMADA LTD

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $222M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

More about KMDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.

Account

Phoenix Holdings Ltd. Kamada LTD Transaction History